VerImmune Inc
June 16, 2025
Company Presentation
Platform for Therapeutics
153C
VerImmune is harnessing the natural geometric structure of viruses to create a self-assembling Virus-inspired Particle (ViP™) platform for targeted therapeutic delivery of diverse payloads for oncology, autoimmunity, and animal health indications
Company HQ City:
Bethesda,
Company HQ State:
MD
Company HQ Country:
United States
Year Founded:
2020
Lead Product in Development:
VERI-101
CEO
Joshua Wang
Development Phase of Lead Product
Pre-Clinical
What is your next catalyst (value inflection) update?
~12 months
Website
www.verimmune.com
Primary Speaker
)
)
){kind=logo}
){kind=logo}
){kind=logo}